Freenome Q3 adj. EPS $1.10 beats estimates; revenue jumps to $183.5M

Freenome reported Q3 adjusted EPS of $1.10, beating the $0.41 estimate, on revenue of $183.5M, up from $1.0M a year earlier. Revenue was driven by $180M recognized under a collaboration and license agreement following FDA approval of its SimpleScreen CRC test. The company ended the quarter with $430M in cash.

Detected & updated continuously · Source: Nebula